ABBV vs ADM Stock Comparison
Scores Breakdown
| Metric | ABBV | ADM |
|---|---|---|
| 📈 Growth | 15/30 | 26/30 |
| 💰 Profitability | 16/20 | 7/20 |
| 🏦 Financial Health | 12/20 | 16/20 |
| 💵 Valuation | 12/20 | 12/20 |
| ⚠️ Risk (lower is better) | 6/10 | 6/10 |
| Overall Score | 59/100 | 65/100 |
Side-by-Side Summaries
| ABBV Analysis | ADM Analysis |
|---|---|
📈 Growth & Financial Trajectory8 quarters show a largely rising topline: 2024Q1 to 2026Q1 Revenues rise from about $12.31B to $15.00B (+≈22%). Net income attributable to parent falls from ~$1.29B to ~$0.70B, though peaks around ~$1.86B in 2025Q2–Q3, with 2025Q4 at ~$1.82B. The trend is mixed: topline strength persists, but bottom-line profitability weakens into 2026Q1. 💰 Margins & Cash FlowGross margins remain high, broadly ~70–79%, reflecting a durable product mix. Operating leverage remains healthy as volumes expand. Net cash flow from operating activities stays robust, typically around $5.1B–$5.3B per quarter; investing activity is negative (capex/activity), and financing flows cause periodic swings. 🛡️ Balance Sheet & LiquidityTotal assets hover near the mid-to-upper hundreds of billions with liabilities that verge on or exceed assets in some periods, and equity attributable to the parent is often negative (reflecting buybacks). The firm generates solid operating cash flow that supports liquidity despite leverage. Long-term debt runs in the mid-$60B range in recent periods, with current liabilities ~$39–$44B. ⚠️ Key Drivers & Risks
|
📈 Growth & Financial TrajectoryOver 8 quarters, ADM's Revenues moved in a narrow band around 19.9–20.5B, ending near 20.49B in Q1 2026 vs 19.94B at the start—a modest +2.9% gain. Net income progressed from about $18M in 2024 Q2 to $303M in 2026 Q1, with a peak of $567M in 2024 Q4, signaling improving profitability despite quarterly volatility. 💰 Margins & Cash FlowGross margin remained steady at about 6.3%–6.8% across the period; operating margin hovered around 2%–3%. Operating cash flow was positive in most quarters (e.g., +4.30B in 2025 Q3, +1.81B in 2025 Q2, +0.15B in 2026 Q1), while investing cash flow was consistently negative, and financing activity varied, reflecting ongoing capital allocation. 🛡️ Balance Sheet & LiquidityAssets run around $52–53B with current assets about $26.6–29B and current liabilities near $18.0–19.6B, giving a healthy current ratio of roughly 1.3–1.5. Debt metrics show long-term debt around $7.6–8.3B and total liabilities around $29–33B, with equity in the low- to mid-$22B range, indicating solid balance-sheet resilience. ⚠️ Key Drivers & Risks
|